Диссертация (1174258), страница 32
Текст из файла (страница 32)
– № 4. – С. E3.177. Qureshi, A.I. Extracellular glutamate and other amino acids inexperimental intracerebral hemorrhage: An in vivo microdialysis study / A.I. Qureshi,Z. Ali, M.F. K. Suri, A. Shuaib, G. Baker, K. Todd, L.R. Guterman, L.N. Hopkins //Crit. Care Med. – 2003. – Т. 31. – № 5. – С. 1482-1489.178. Qureshi, A.I. Intracerebral haemorrhage / A.I. Qureshi, A.D. Mendelow,D.F.
Hanley // Lancet. – 2009. – Т. 373. – № 9675. – С. 1632-1644.179. Qureshi, A.I. Intensive Blood-Pressure Lowering in Patients with AcuteCerebral Hemorrhage / A.I. Qureshi, Y.Y. Palesch, W.G. Barsan, D.F. Hanley, C.Y.Hsu, R.L. Martin, C.S. Moy, R. Silbergleit, T.
Steiner, J.I. Suarez, K. Toyoda, Y.Wang, H. Yamamoto, B.-W. Yoon // N. Engl. J. Med. – 2016. – Т. 375 – № 11. – С.1033-1043.180. Qureshi, A.I. Spontaneous intracerebral hemorrhage / A.I. Qureshi,S.Tuhrim, J.P. Broderick, H.H. Batjer, H. Hondo, D.F.
Hanley // N. Engl. J. Med. –2001. – Т. 344. – № 19. – С. 1450-1460.181. Rauch, A. On the Versatility of von Willebrand Factor / A. Rauch, N.Wohner, O.D. Christophe, C.V. Denis, S. Susen, P.J. Lenting // Mediterr. J. Hematol.Infect. Dis. – 2013. – Т. 5. – № 1. – С. e2013046.182. Ray, B. Management of anticoagulant-related intracranial hemorrhage: anevidence-based review / B. Ray, S.G. Keyrouz // Crit. Care.
– 2014. – Т. 18. – № 3 –С. 223.183. Reheman, A. Mice with deleted multimerin 1 and alpha-synuclein geneshave impaired platelet adhesion and impaired thrombus formation that is corrected bymultimerin 1 / A. Reheman, S. Tasneem, H. Ni, C.P.M. Hayward // Thromb. Res. –2010. – Т. 125.
– № 5. – С. E177-E183.184. Reininger, A.J. Platelet function under high shear conditions / A.J.Reininger // Hamostaseologie. – 2009. – Т. 29. – № 1 – С. 21-22.187185. Reynolds, M.A. Early biomarkers of stroke / M.A. Reynolds, H.J.Kirchick, J.R. Dahlen, J.M. Anderberg, P.H. McPherson, K.K. Nakamura, D.T.Laskowitz, G.E. Valkirs, K.F. Buechler // Clin. Chem. – 2003. – Т.
49. – № 10. – С.1733-1739.186. Romani de Wit, T. Real-time imaging of the dynamics and secretorybehavior of Weibel-Palade bodies / T. Romani de Wit, M.G. Rondaij, P.L. Hordijk, J.Voorberg, J.A. van Mourik // Arterioscler. Thromb. Vasc. Biol. – 2003. – Т. 23. – №5. – С.
755-761.187. Rondaij, M.G. Dynamics and Plasticity of Weibel-Palade Bodies inEndothelial Cells / M.G. Rondaij, R. Bierings, A. Kragt, J.A. van Mourik, J.Voorberg // Arterioscler. Thromb. Vasc. Biol. – 2006. – Т. 26. – № 5. – С. 10021007.188. Roquer, J. Previous antiplatelet therapy is an independent predictor of 30day mortality after spontaneous supratentorial intracerebral hemorrhage / J. Roquer,A. R. Campello, M. Gomis, A. Ois, V. Puente, E.
Munteis // J. Neurol. – 2005. – Т.252. – № 4. – С. 412-416.189. Rosamond, W.D. Stroke incidence and survival among middle-agedadults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort /W.D. Rosamond, A.R. Folsom, L.E. Chambless, C.H. Wang, P.G. McGovern, G.Howard, L.S. Copper, E. Shahar // Stroke J. Cereb. Circ. – 1999. – Т. 30. – № 4 – С.736-743.190. Rumbaut, R.E. Platelet-Vessel Wall Interactions in Hemostasis andThrombosis / R.E. Rumbaut, P. Thiagarajan – San Rafael (CA): Morgan & ClaypoolLife Sciences, 2010.191.
Russell, F.D. Secretory pathways in endothelin synthesis / F.D. Russell,A.P. Davenport // Br. J. Pharmacol. – 1999. – Т. 126. – № 2. – С. 391-398.192. Russell, F.D. Human endothelial cell storage granules - A novelintracellular site for isoforms of the endothelin-converting enzyme / F.D. Russell,J.N.
Skepper, A.P. Davenport // Circ. Res. – 1998. – Т. 83. – № 3. – С. 314-321.188193. Rydz, N. The C-type lectin receptor CLEC4M binds, internalizes, andclears von Willebrand factor and contributes to the variation in plasma vonWillebrand factor levels / N. Rydz, L.L. Swystun, C.
Notley, A.D. Paterson, J.J.Riches, K. Sponagle, B. Boonyawat, R.R. Montgomery, P.D. James, D. Lillicrap //Blood. – 2013. – Т. 121. – № 26. – С. 5228-5237.194. Sabayan, B. Markers of endothelial dysfunction and cerebral blood flowin older adults / B. Sabayan, R.G. Westendorp, J. van der Grond, D.J. Stott, N. Sattar,M.J.P. van Osch, M.A.
van Buchem, A.J.M. de Craen // Neurobiol. Aging. – 2014. –Т. 35. – № 2. – С. 373-377.195. Sadler, J.E. Biochemistry and genetics of von Willebrand factor / J.E.Sadler // Annu. Rev. Biochem. – 1998. – Т. 67. – С. 395-424.196. Sadler, J.E. von Willebrand factor: two sides of a coin / J.E. Sadler // J.Thromb. Haemost.
– 2005. – Т. 3. – № 8. – С. 1702-1709.197. Sadler, J.E. Von Willebrand factor, ADAMTS13, and thromboticthrombocytopenic purpura / J.E. Sadler // Blood. – 2008. – Т. 112. – № 1. – С. 11-18.198. Sadler, J.E. What’s new in the diagnosis and pathophysiology ofthrombotic thrombocytopenic purpura / J.E. Sadler // Hematol.-Am. Soc. Hematol.Educ.
Program. – 2015. – С. 631-636.199. Saint-Lu, N. Identification of Galectin-1 and Galectin-3 as Novel Partnersfor Von Willebrand Factor / N. Saint-Lu, B.D. Oortwijn, J.N. Pegon, S. Odouard,O.D. Christophe, P.G. de Groot, C.V. Denis, P.J. Lenting // Arterioscler. Thromb.Vasc. Biol. – 2012. – Т. 32. – № 4. – С. 894-901.200. Samai, A. Von Willebrand Factor Drives the Association BetweenElevated Factor VIII and Poor Outcomes in Patients With Ischemic Stroke / A.Samai, D.
Monlezun, A. Shaban, A. George, L. Dowell, R. Kruse-Jarres, L. Schluter,R. El Khoury, S. Martin-Schild // Stroke. – 2014. – Т. 45. – № 9. – С. 2789-2791.201. Saxena, A. Prognostic Significance of Hyperglycemia in AcuteIntracerebral Hemorrhage The INTERACT2 Study / A. Saxena, C.S. Anderson, X.Wang, S.
Sato, H. Arima, E. Chan, P. Munoz-Venturelli, C. Delcourt, T. Robinson,189C. Stapf, P.M. Lavados, J. Wang, B. Neal, J. Chalmers, E. Heeley // Stroke. – 2016. –Т. 47. – № 3. – С. 682-688.202. Scharpfenecker, M. The Tie-2 ligand angiopoietin-2 destabilizes quiescentendothelium through an internal autocrine loop mechanism / M. Scharpfenecker, U.Fiedler, Y. Reiss, H. G. Augustin // J.
Cell Sci. – 2005. – Т. 118. – № 4. – С. 771780.203. Schnyder-Candrian, S. Localization of alpha 1,3-fucosyltransferase VI inWeibel-Palade bodies of human endothelial cells / S. Schnyder-Candrian, L. Borsig,R. Moser, E.G. Berger // Proc. Natl. Acad. Sci. U.S.A. – 2000. – Т. 97.
– № 15. – С.8369-8374.204. Schooten, C.J. van Macrophages contribute to the cellular uptake of vonWillebrand factor and factor VIII in vivo / C.J. van Schooten, S. Shahbazi, E. Groot,B.D. Oortwijn, H.M. van den Berg, C.V. Denis, P.J. Lenting // Blood. – 2008. – Т.112. – № 5. – С. 1704-1712.205.
Shapiro, S.E. The von Willebrand factor predicted unpaired cysteines areessential for secretion / S.E. Shapiro, A.A. Nowak, C. Wooding, G. Birdsey, M.A.Laffan, T.A.J. McKinnon // J. Thromb. Haemost. – 2014. – Т. 12. – № 2. – С. 246254.206. Shida, Y. Functional imaging of shear-dependent activity of ADAMTS13in regulating mural thrombus growth under whole blood flow conditions / Y. Shida,K. Nishio, M. Sugimoto, T.
Mizuno, M. Hamada, S. Kato, M. Matsumoto, K.Okuchi, Y. Fujimura, A. Yoshioka // Blood. – 2008. – Т. 111. – № 3. – С. 12951298.207. Shim, K. Platelet-VWF complexes are preferred substrates ofADAMTS13 under fluid shear stress / K. Shim, P.J. Anderson, E.A. Tuley, E.Wiswall, J.E. Sadler // Blood. – 2008. – Т. 111. – № 2. – С. 651-657.208.Simard,J.M.Brainoedemainfocalischaemia:molecularpathophysiology and theoretical implications / J.M. Simard, T.A. Kent, M. Chen,K.V.
Tarasov, V. Gerzanich // Lancet Neurol. – 2007. – Т. 6. – № 3. – С. 258-268.190209. Skeppholm, M. ADAMTS13 and von Willebrand factor concentrations inpatients with diabetes mellitus / M. Skeppholm, A. Kallner, M. Kalani, G. Jorneskog,M. Blomback, H.N. Wallen // Blood Coagul.
Fibrinolysis. – 2009. – Т. 20. – № 8. –С. 619-626.210. Sobel, M. Heparin inhibition of von Willebrand factor-dependent plateletfunction in vitro and in vivo / M. Sobel, P.M. McNeill, P.L. Carlson, J.C. Kermode,B. Adelman, R. Conroy, D. Marques // J. Clin. Invest. – 1991. – Т.
87. – № 5. – С.1787-1793.211. Somanath, P.R. Cooperation between integrin αvβ3 and VEGFR2 inangiogenesis / P.R. Somanath, N.L. Malinin, T.V. Byzova // Angiogenesis. – 2009. –Т. 12. – № 2. – С. 177-185.212. Song, J. Quantitative Influence of ABO Blood Groups on Factor VIII andIts Ratio to von Willebrand Factor, Novel Observations from an ARIC Study of11,673 Subjects / J.
Song, F. Chen, M. Campos, D. Bolgiano, K. Houck, L.E.Chambless, K.K. Wu, A.R. Folsom, D. Couper, E. Boerwinkle, J. Dong // Plos One. –2015. – Т. 10. – № 8. – С. e0132626.213. Sonneveld, M.A.H. Von Willebrand Factor, ADAMTS13, and the Risk ofMortality The Rotterdam Study / M.A.H. Sonneveld, O.H. Franco, M.A. Ikram, A.Hofman, M. Kavousi, M.P.M. de Maat, F.W.G.
Leebeek // Arterioscler. Thromb.Vasc. Biol. – 2016. – Т. 36. – № 12. – С. 2446-2451.214. Sonneveld, M.A.H. Low ADAMTS13 activity is associated with anincreased risk of ischemic stroke / M.A.H. Sonneveld, M.P.M. de Maat, M.L.P.Portegies, M. Kavousi, A. Hofman, P.L. Turecek, H. Rottensteiner, F.
Scheiflinger,P.J. Koudstaal, M.A. Ikram, F.W.G. Leebeek // Blood. – 2015. – Т. 126. – № 25. – С.2739-2746.215. Starke, R.D. Endothelial von Willebrand factor regulates angiogenesis /R.D. Starke, F. Ferraro, K.E. Paschalaki, N.H. Dryden, T.A.J. McKinnon, R.E.Sutton, E.M. Payne, D.O. Haskard, A.D.
Hughes, D.F. Cutler, M.A. Laffan, A.M.Randi // Blood. – 2011. – Т. 117. – № 3. – С. 1071-1080.191216. Stokum, J.A. Molecular pathophysiology of cerebral edema / J.A.Stokum, V. Gerzanich, J.M. Simard // J. Cereb. Blood Flow Metab. – 2016. – Т. 36. –№ 3.
– С. 513-538.217. Stoll, M. Rare Variants in the ADAMTS13 Von Willebrand FactorBinding Domain Contribute to Pediatric Stroke / M. Stoll, F. Ruehle, A. Witten, A.Barysenka, A. Arning, C. Strauss, U. Nowak-Goettl // Circ.-Cardiovasc. Genet. –2016. – Т. 9. – № 4.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
